Aspire Biopharma Holdings, Inc. (ASBPW) Revenue History
Annual and quarterly revenue from 2021 to present
ASBPW Revenue Over Time (2021–2025)
ASBPW Revenue Growth History
- FY2021 revenue growth
- N/A
- FY2022 revenue growth
- N/A
- FY2023 revenue growth
- N/A
- FY2024 revenue growth
- N/A
- FY2025 revenue growth
- N/A
| Quarter | Revenue | YoY |
|---|---|---|
| Q1 2026 | $28K | — |
| Q4 2025 | $4K | — |
| Q3 2025 | $2K | — |
| Q2 2025 | $0 | — |
| Q1 2025 | $0 | — |
| Q4 2024 | $0 | — |
| Q3 2024 | $0 | — |
| Q2 2024 | $0 | — |
Multi-year avg. share of annual revenue by fiscal quarter
ASBPW Revenue Analysis (2021–2025)
Current Revenue & Growth
As of June 28, 2026, Aspire Biopharma Holdings, Inc. (ASBPW) generated trailing twelve-month (TTM) revenue of $34,555. The most recent quarter (Q1 2026) recorded $28,353 in revenue, up 565.4% sequentially.
Historical Growth Trajectory
ASBPW's historical revenue data shows various trends over time. Aspire Biopharma Holdings, Inc.'s highest annual revenue of $6,202 was recorded in 2025, an all-time high.
Peer Comparison
Compared to Healthcare sector peers — including SNDL (+1.1% YoY), GRWG (-6.9% YoY), and IIPR (-13.6% YoY). Compare ASBPW vs SNDL →
ASBPW Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| ASBPWCurrent | $34,555 | - | - | -312016.9% | |
 SNDL | $946M | +1.1% | +73.1% | -0.5% | |
 GRWG | $162M | -6.9% | -3.5% | -15.0% | |
 IIPR | $266M | -13.6% | +17.9% | 46.7% | |
 ACB | $321M | -9.4% | +5.6% | -50.8% | |
 HYFM | $134M | -30.8% | -17.1% | -29.4% |
ASBPW Historical Revenue Data (2021–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $6K | - | $-116 | -1.9% | $-19,351,291 | -312016.9% |
| 2024 | $0 | - | $0 | - | $-3,088,671 | - |
| 2023 | $0 | - | $0 | - | $-1,340,000 | - |
| 2022 | $0 | - | $0 | - | $-976,345 | - |
| 2021 | $0 | - | $0 | - | $-25,480 | - |
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
5+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
ASBPW — Frequently Asked Questions
Quick answers to the most common questions about buying ASBPW stock.
Is ASBPW's revenue growth accelerating or slowing?
ASBPW TTM revenue: $34555.00. YoY growth: N/A. 5-year CAGR: N/A.
What is ASBPW's revenue history from 2021 to 2026?
Aspire Biopharma Holdings, Inc. (ASBPW) revenue history spans 2021 to 2026. TTM revenue as of 2026 is $34555.00, growing at N/A YoY. The 5-year CAGR is N/A. Complete annual and quarterly revenue figures are available on this page, including gross profit, operating income, and margin trends.
What is ASBPW's long-term revenue growth rate (CAGR)?
Aspire Biopharma Holdings, Inc.'s 5-year revenue CAGR of N/A reflects the variable nature of its business expansion. As of 2026, the current YoY growth rate of N/A is in line with this long-term average. CAGR is the most reliable measure of sustained revenue momentum for ASBPW.
Why does ASBPW's quarterly revenue fluctuate?
ASBPW quarterly revenue can fluctuate significantly between periods. A quarter-over-quarter (QoQ) change does not always indicate a trend; comparing the same quarter year-over-year (YoY) is a more reliable signal for underlying growth. Aspire Biopharma Holdings, Inc.'s revenue data from 2021 to 2026 shows full historical quarterly detail on this page.
How is ASBPW's revenue distributed by segment?
ASBPW reports revenue broken down by product line and geographic region. The segment breakdown on this page shows which business units contribute the most to total revenue as of the latest fiscal year. Concentration in a single segment above 50% indicates category dependence, while a diversified mix signals more resilient revenue streams.
How does ASBPW's revenue compare to industry peers?
Aspire Biopharma Holdings, Inc. (ASBPW) with TTM revenue of $34555.00 and N/A YoY growth can be benchmarked against sector peers using the comparison table on this page. Revenue growth relative to peers indicates market share gains or losses. The peer section shows TTM revenue, YoY growth, and operating margin for direct comparisons.